» Articles » PMID: 10692421

Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 Versus SUMO-2/3

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Feb 29
PMID 10692421
Citations 387
Authors
Affiliations
Soon will be listed here.
Abstract

Post-translational modification marked by the covalent attachment of the ubiquitin-like protein SUMO-1/SMT3C has been implicated in a wide variety of cellular processes. Recently, two cDNAs encoding proteins related to SUMO-1 have been identified in human and mouse. The functions and regulation of these proteins, known as SUMO-2/SMT3A and SUMO-3/SMT3B, remain largely uncharacterized. We describe herein quantitative and qualitative distinctions between SUMO-1 and SUMO-2/3 in vertebrate cells. Much of this was accomplished through the application of an antibody that recognizes SUMO-2 and -3, but not SUMO-1. This antibody detected multiple SUMO-2/3-modified proteins and revealed that, together, SUMO-2 and -3 constitute a greater percentage of total cellular protein modification than does SUMO-1. Intriguingly, we found that there was a large pool of free, non-conjugated SUMO-2/3 and that the conjugation of SUMO-2/3 to high molecular mass proteins was induced when the cells were subjected to protein-damaging stimuli such as acute temperature fluctuation. In addition, we demonstrated that SUMO-2/3 conjugated poorly, if at all, to a major SUMO-1 substrate, the Ran GTPase-activating protein RanGAP1. Together, these results support the concept of important distinctions between the SUMO-2/3 and SUMO-1 conjugation pathways and suggest a role for SUMO-2/3 in the cellular responses to environmental stress.

Citing Articles

Regulation of the immune microenvironment by SUMO in diabetes mellitus.

Zhuo Y, Fu S, Qiu Y Front Immunol. 2025; 16:1506500.

PMID: 40078991 PMC: 11896877. DOI: 10.3389/fimmu.2025.1506500.


Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease.

Fioriti L, Wijesekara N, Argyrousi E, Matsuzaki S, Takamura H, Satoh K Alzheimers Dement. 2025; 21(3):e70030.

PMID: 40047257 PMC: 11883658. DOI: 10.1002/alz.70030.


Non-Invasive Assessment of Neurogenesis Dysfunction in Fetuses with Early-Onset Growth Restriction Using Fetal Neuronal Exosomes Isolating from Maternal Blood: A Pilot Study.

Gusar V, Kan N, Leonova A, Chagovets V, Tyutyunnik V, Khachatryan Z Int J Mol Sci. 2025; 26(4).

PMID: 40003962 PMC: 11855093. DOI: 10.3390/ijms26041497.


Comprehensive SUMO Proteomic Analyses Identify HIV Latency-Associated Proteins in Microglia.

Imbert F, Langford D Cells. 2025; 14(3).

PMID: 39937027 PMC: 11817477. DOI: 10.3390/cells14030235.


Deciphering the endogenous SUMO-1 landscape: a novel combinatorial peptide enrichment strategy for global profiling and disease association.

Zhang X, Zhong B, Sun Y, Liu D, Zhang X, Wang D Chem Sci. 2025; 16(6):2634-2647.

PMID: 39802689 PMC: 11712212. DOI: 10.1039/d4sc07379g.